1. Home
  2. ATAI vs LCNB Comparison

ATAI vs LCNB Comparison

Compare ATAI & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • LCNB
  • Stock Information
  • Founded
  • ATAI 2018
  • LCNB 1877
  • Country
  • ATAI Germany
  • LCNB United States
  • Employees
  • ATAI N/A
  • LCNB N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • LCNB Major Banks
  • Sector
  • ATAI Health Care
  • LCNB Finance
  • Exchange
  • ATAI Nasdaq
  • LCNB Nasdaq
  • Market Cap
  • ATAI 214.8M
  • LCNB 212.3M
  • IPO Year
  • ATAI 2021
  • LCNB N/A
  • Fundamental
  • Price
  • ATAI $1.24
  • LCNB $15.83
  • Analyst Decision
  • ATAI Strong Buy
  • LCNB
  • Analyst Count
  • ATAI 4
  • LCNB 0
  • Target Price
  • ATAI $9.00
  • LCNB N/A
  • AVG Volume (30 Days)
  • ATAI 1.3M
  • LCNB 26.1K
  • Earning Date
  • ATAI 11-13-2024
  • LCNB 01-29-2025
  • Dividend Yield
  • ATAI N/A
  • LCNB 5.77%
  • EPS Growth
  • ATAI N/A
  • LCNB N/A
  • EPS
  • ATAI N/A
  • LCNB 0.52
  • Revenue
  • ATAI $331,000.00
  • LCNB $74,686,000.00
  • Revenue This Year
  • ATAI $93.15
  • LCNB N/A
  • Revenue Next Year
  • ATAI N/A
  • LCNB $15.49
  • P/E Ratio
  • ATAI N/A
  • LCNB $29.28
  • Revenue Growth
  • ATAI N/A
  • LCNB 3.03
  • 52 Week Low
  • ATAI $1.03
  • LCNB $12.42
  • 52 Week High
  • ATAI $2.85
  • LCNB $17.92
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 33.95
  • LCNB 36.98
  • Support Level
  • ATAI $1.15
  • LCNB $15.51
  • Resistance Level
  • ATAI $1.69
  • LCNB $16.84
  • Average True Range (ATR)
  • ATAI 0.11
  • LCNB 0.55
  • MACD
  • ATAI -0.06
  • LCNB -0.21
  • Stochastic Oscillator
  • ATAI 3.69
  • LCNB 22.75

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

Share on Social Networks: